Canthacur Liq. 0.7%

Testo originale in francese.

Prodotto naturale per la salute autorizzato in Canada

Titolare

Paladin Pharma Inc.

NPN o DIN-HM

80028872

Stato

Licenza non attiva

Data della licenza

4 gennaio 2012

Data di revisione

Non indicata

Forma

Liquide

Via di somministrazione

Topique

Tipo di domanda

Non traditionnelle

Composizione

Composizione medicinale non indicata.

Ingredienti non medicinali

Monoéthyl éther d'éthylène glycol, Triton X-45, Ethylcellulose, Acetone, Collodion, Castor Oil

Dosi raccomandate in Canada

Usi autorizzati in Canada

Canthacur is to be used topically for the removal of benign epithelial growths such as warts (verruca vulgaris) or molluscum contagiosum. Because of the absence of scarring. Canthacur is useful for treating exposed areas where cosmetic results are important. Painless application and the absence of instruments make it especially useful for treating children.

Testo originale in inglese.

Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.

Avvertenze in Canada

Cautions and Warnings : Cantharidin is a strong vesicant and Canthacur may produce blisters if it comes into contact with normal skin or mucous membrane. If spilled on skin, wipe off at once, using acetone, alcohol or tape remover. Then wash vigorously with warm soapy water and rinse well. If spilled on mucous membrane or in eyes, flush with water, remove the precipitated film, and flush with water for an additional 15 minutes. Canthacur is a potent vesicant and is to be applied only by the doctor. It is recommended that care be used in the selection of patients to be treated with Canthacur and the method used, the doctor developing his own experience and technique. Care should be used in selection of site of application since residual pigmentation may occur (rarely). It is recommended that patients be advised of effect and possible results of treatment. Do not use on mucosal tissue. Do not use if growth or surrounding tissue is inflamed or irritated. Do not use on diabetics, or people with poor blood circulation, nor on moles, birthmarks, or unusual warts with hair growing from them. Larger areas should not be treated at one time since discomfort may be excessive and systemic absorption may result. The use of Canthacur during pregnancy or in nursing mothers is not recommended since there have been no adequate and well controlled studies in the use of cantharidin in pregnant women or in nursing mothers.

Testo originale in inglese.

Contra-Indications : Canthacur is not recommended for the treatment of mosaic warts.

Testo originale in inglese.

Known Adverse Reactions : The development of annular warts following Canthacur therapy has been reported in a small percentage of patients. These lesions are superficial and, although they may alarm some patients, present little problem. Treatment consists of patient reassurance and retreatment using either Canthacur or other procedures. There has been one report of chemical lymphangitis following use of Canthacur in combination with salicylic acid plaster.

Testo originale in inglese.

Fonte

Scheda ufficiale Health Canada, licenza 80028872

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Testo originale in inglese.

La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.

La data della prova di questo elenco di ingredienti è sconosciuta.

Il prodotto è cambiato? Fotografi la confezione.

Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.